Pfizer’s recent 80,000-page data dump has received zero coverage in the mainstream media.
While the pharmaceutical company’s COVID-19 jab data should be among the stories of the year, establishment pundits have remained silent.
We asked why the mainstream media refuses to report on Pfizer’s abysmal data.
However, there was one sliver of mainstream coverage on Pfizer's experimental shots that I'd like to share.
Unsurprisingly, the clip comes from Tucker Carlson of Fox News.
Carlson interviewed Dr. Aaron Kheriaty on his program.
Dr. Kheriaty is the Chief of Ethics at The Unity Project.
Watch the interview below:
Dr. Aaron Kheriaty @akheriaty on @TuckerCarlson last night discussing the Pfizer clinical trial data and Excess Mortality of mRNA vaccines.
Dr. Kheriaty is the Chief of Ethics at the @UnityProjectUSA
——————
Source: @FoxNews @backtolife_2022 pic.twitter.com/Z7BwTHP76v— Te𝕏asLindsay™ (@TexasLindsay_) May 7, 2022
"We had to file this Freedom of Information Act (FOIA), myself and some of my colleagues last September, just to get the Pfizer data," Kheriaty said.
"Now we're starting to get that data after many people have already taken the vaccine."
While the FDA limited the use of Johnson & Johnson's COVID-19 shot due to blood clots, Dr. Kheriaty noted his surprise there's not more scrutiny to the mRNA COVID-19 shots.
"If you look at overall safety issues, the J&J vaccine probably has the better overall safety profile," he continued.
"It might have higher incidence of thrombosis, but there was another recent very important study on all-cause mortality."
Dr. Kheriaty explained that researchers compared all three shots on all-cause mortality. Are you more likely to live or die after taking this vaccine?
While the J&J shot showed a modest improvement in all-cause mortality, the mRNA shots (Pfizer and Moderna) showed no improvement in all-cause mortality.
He reiterated that he'd like to see the same level of scrutiny applied to all the shots.
Find all Pfizer documents HERE.
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!